123 related articles for article (PubMed ID: 18257776)
1. Statins and natural regulatory T cells in HIV infection.
Mascitelli L; Pezzetta F; Goldstein MR
HIV Med; 2008 Feb; 9(2):131. PubMed ID: 18257776
[No Abstract] [Full Text] [Related]
2. Complications and side effects. Concerns about statins.
TreatmentUpdate; 2005; 17(4):5-6. PubMed ID: 17228472
[No Abstract] [Full Text] [Related]
3. Room for manoeuvre when prescribing statins to dyslipidaemic patients on antiretroviral therapy.
Myers J; Rayment M; Sonecha S; Moyle G; Boffito M
HIV Med; 2012 Mar; 13(3):190-2. PubMed ID: 22296166
[No Abstract] [Full Text] [Related]
4. Lipid lowering, statins and cancer.
Wierzbicki AS
Int J Clin Pract; 2006 Sep; 60(9):1022-4. PubMed ID: 16939539
[No Abstract] [Full Text] [Related]
5. Fenofibric Acid (trilipix).
Med Lett Drugs Ther; 2009 May; 51(1311):33-4. PubMed ID: 19417718
[No Abstract] [Full Text] [Related]
6. Re: Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
Yoshii Y; Ikeda K; Iwamoto K; Kawase Y; Iwasaki Y
Neurology; 2009 Mar; 72(10):944; author reply 944-5. PubMed ID: 19273834
[No Abstract] [Full Text] [Related]
7. Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
Polonsky TS; Davidson MH
Am J Cardiol; 2008 Apr; 101(8A):27B-35B. PubMed ID: 18375238
[TBL] [Abstract][Full Text] [Related]
8. Statins and cancer in patients with asthma.
Mascitelli L; Pezzetta F; Goldstein MR
Thorax; 2009 Jun; 64(6):548-9; author reply 549. PubMed ID: 19478124
[No Abstract] [Full Text] [Related]
9. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE; Sowell MO; Stender M; Qizilbash N
Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
[TBL] [Abstract][Full Text] [Related]
10. Lipid management in chronic kidney disease, hemodialysis, and transplantation.
Montague T; Murphy B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521
[TBL] [Abstract][Full Text] [Related]
11. Statins and cancer: will we ever know the answer?
Etminan M; Coogan PF; Rosenberg L
Epidemiology; 2002 Sep; 13(5):607; author reply 607-8. PubMed ID: 12192235
[No Abstract] [Full Text] [Related]
12. Complications & side effects. Can statins be used as anti-HIV drugs?
TreatmentUpdate; 2004; 16(7):9. PubMed ID: 17219689
[No Abstract] [Full Text] [Related]
13. Lipid management in the geriatric patient.
Nair AP; Darrow B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
[TBL] [Abstract][Full Text] [Related]
14. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.
Zanetti HR; Roever L; Gonçalves A; Resende ES
Curr Atheroscler Rep; 2018 Feb; 20(2):9. PubMed ID: 29423787
[TBL] [Abstract][Full Text] [Related]
15. Statin-fibrate combination therapy.
Feeman WE
Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
[No Abstract] [Full Text] [Related]
16. The double-edged sword of statin immunomodulation.
Goldstein MR; Mascitelli L; Pezzetta F
Int J Cardiol; 2009 Jun; 135(1):128-30. PubMed ID: 18485499
[TBL] [Abstract][Full Text] [Related]
17. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral and statin drug-drug interactions.
Ray GM
Cardiol Rev; 2009; 17(1):44-7. PubMed ID: 19092370
[TBL] [Abstract][Full Text] [Related]
19. [Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia].
Kłosiewicz-Latoszek L; Cybulska B
Kardiol Pol; 2005 Jun; 62 Suppl 2():II76-80. PubMed ID: 19813341
[No Abstract] [Full Text] [Related]
20. Lipid-lowering therapy--benefits and risks.
Shechter M
Isr Med Assoc J; 2007 Feb; 9(2):133; author reply 133-4. PubMed ID: 17348492
[No Abstract] [Full Text] [Related]
[Next] [New Search]